鼻咽癌MRI定量颈部淋巴结坏死负荷的预后价值及其作为诱导化疗分层标志的作用
本研究纳入1319例鼻咽癌患者,评估MRI定量颈部淋巴结坏死(CNN)负荷的预后价值。多变量Cox回归显示,多个CNN(≥3个坏死淋巴结)是远处无转移生存(DMFS)和无进展生存(PFS)的独立预后因素,将其升级为N3期可改善AJCC分期系统的预后区分能力。多个CNN患者接受CCRT联合诱导化疗的总生存优于单纯CCRT(76.1% vs 55.7%;校正P=0.030)。
要点
- 多个CNN(≥3个坏死淋巴结)是DMFS(校正HR 2.05;P=0.020)和PFS(HR 1.78;P=0.004)的独立预后因素。
- 将多个CNN患者升级为N3期可扩大N2与N3期之间DMFS和PFS的差异。
- 多个CNN患者接受CCRT联合诱导化疗的总生存优于单纯CCRT(76.1% vs 55.7%;校正P=0.030)。
核心结论
- 将多个CNN患者升级为N3期可能改善当前AJCC分期系统的预后判断;多个CNN可能是筛选能从诱导化疗中获益患者的潜在标志物。
研究设计与样本
- 研究纳入1319例鼻咽癌患者,基于MRI图像评估淋巴结变量,采用单变量和多变量Cox回归分析其与生存的关联,并提出N分类系统修订版与第8版AJCC分期系统进行比较(使用Harrell一致性指数)。
诊断标准与关键数值
- 多个CNN定义为三个或更多坏死淋巴结;多变量分析中,多个CNN对DMFS的校正HR为2.05(P=0.020),对PFS的HR为1.78(P=0.004)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to assess the prognostic value of quantitative cervical nodal necrosis (CNN) burden in N staging risk stratification in patients with nasopharyngeal carcinoma.
METHODS: Univariate and multivariate Cox regression models evaluated the association between lymph node variables based on MRI images and survival. Revisions for the N classification system were proposed and compared to the 8th edition AJCC staging system using Harrell's concordance index (C-index). The survival outcomes of induction chemotherapy plus concurrent chemoradiotherapy (CCRT) and CCRT alone in patients with multiple CNNs were compared.
RESULTS: In 1319 patients enrolled, CNN was not an independent prognostic factor for the main survival outcomes, but multiple CNNs (three or more necrotic nodes) were independent prognostic factors for distant metastasis-free survival (DMFS) (adjusted hazard ratio [HR], 2.05; p = 0.020) and progression-free survival (PFS) (HR, 1.78; p = 0.004), surpassing other nodal variables. On upgrading patients with multiple CNNs to revised N3 disease, the proposed N staging widened the differences in DMFS and PFS between N2 and N3 disease. The overall survival of patients with multiple CNNs who received CCRT plus induction chemotherapy was improved compared to that of those who received CCRT alone (76.1% vs. 55.7%; adjusted p = 0.030).
CONCLUSIONS: Upgrading patients with multiple CNNs to stage N3 may improve prognostication of the current AJCC staging system. Multiple CNNs might be a potential marker for stratifying patients who would benefit from induction chemotherapy.
KEY POINTS: • Quantitatively assessed the prognostic value of CNN burden in patients with NPC. • Upgrading patients with multiple CNNs to stage N3 may improve prognostication. • Multiple CNNs may be used as a stratification marker for induction chemotherapy.
引用
- Li, Zhao, Zhang, et al. Prognostic value of quantitative cervical nodal necrosis burden on MRI in nasopharyngeal carcinoma and its role as a stratification marker for induction chemotherapy. Eur Radiol. 2022. PMID: 35437613. doi:10.1007/s00330-022-08785-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。